John F. Sheridan
2018
Compensation breakdown
Non-Equity Incentive Plan | $350,863 |
---|---|
Option Awards | $1,197,532 |
Salary | $386,250 |
Other | $2,772 |
Total | $1,937,417 |
Sheridan received $1.2M in option awards, accounting for 62% of the total pay in 2018.
Sheridan also received $350.9K in non-equity incentive plan, $386.3K in salary and $2.8K in other compensation.
Rankings
In 2018, John F. Sheridan's compensation ranked 5,912th out of 14,244 executives tracked by ExecPay. In other words, Sheridan earned more than 58.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,912 out of 14,244 | 59th |
Division Manufacturing | 2,249 out of 5,765 | 61st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 280 out of 849 | 67th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 154 out of 547 | 72nd |
Industry Surgical and Medical Instruments and Apparatus | 98 out of 348 | 72nd |
Pay ratio
John F. Sheridan's Pay | $1,937,417 |
---|---|
Median Employee's Pay | $142,953 |
Pay Ratio | 14to 1 |
In 2018, the annual total compensation of John F. Sheridan was $1,937,417.
The annual total compensation of the median employee at Tandem Diabetes Care was $142,953.
The ratio of John F. Sheridan's pay to the pay of median employee was therefore 14 to one.
Sheridan's colleagues
We found four more compensation records of executives who worked with John F. Sheridan at Tandem Diabetes Care in 2018.